Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
---|
10/11/2012 | US20120258043 Linkable Lewis X Analogs |
10/11/2012 | US20120258042 Combined use of tgf-b signaling inhibitor and antitumor agent |
10/11/2012 | US20120258040 Compositions and methods of monoclonal and polyclonal antibodies specific for t cell subpopulations |
10/11/2012 | DE10352433B4 Polypeptid eines Silicatein-ß aus Suberites domuncula, dafür kodierende Nukleinsäure, deren Verwendungen, diese Nukleinsäure umfassender Vektor und dieses Polypeptid exprimierende Wirtszelle A polypeptide silicatein-ß from Suberites domuncula, nucleic acid coding which uses this vector comprising the nucleic acid and polypeptide expressing this host cell |
10/11/2012 | CA2832735A1 Method of inducing neutralizing antibodies to human immunodeficiency virus |
10/11/2012 | CA2832556A1 Formulations with reduced viscosity |
10/11/2012 | CA2832486A1 Ophthalmic preparations based on pacap (pituitary adenylate cyclase activating polypeptide) which restore the normal visual function in early glaucoma |
10/11/2012 | CA2832303A1 Pharmaceutical preparation |
10/11/2012 | CA2832130A1 Pharmaceutical composition |
10/11/2012 | CA2831847A1 Sugar and peg functionalized polyacetals with controlled ph-dependent degradation |
10/11/2012 | CA2830372A1 Long-acting peptide analogs |
10/10/2012 | EP2508544A1 Degradable polyacetal polymers |
10/10/2012 | EP2508341A1 Compositions comprising elemental metals and uses therefor |
10/10/2012 | EP2508207A1 Nanoparticles loaded with chemotherapeutic antitumoral Drug |
10/10/2012 | EP2508206A1 Film coating agent for solid preparation, and solid preparation using same |
10/10/2012 | EP2508205A2 Preserved compositions containing hyaluronic acid or a pharmaceutically- acceptable salt thereof and related methods |
10/10/2012 | EP2508187A1 Triflusal powder containing cyclodextrin as a stabilizing agent |
10/10/2012 | EP2508176A1 Novel combination treatment of cancer |
10/10/2012 | EP2508174A1 Pharmaceutical composition |
10/10/2012 | EP2508171A1 Pharmaceutical magnetic nano-particle composition |
10/10/2012 | EP2508169A1 Polymersome and process for producing same |
10/10/2012 | EP2506880A1 Compositions comprising nonsteroidal anti - inflammatory drugs |
10/10/2012 | EP2506879A1 Snalp formulations containing antioxidants |
10/10/2012 | EP2506878A2 Process for preparing pharmaceutical ophthalmic compositions |
10/10/2012 | EP2506868A2 Factor viii-fc chimeric and hybrid polypeptides, and methods of use thereof |
10/10/2012 | EP2506858A1 Starch derivative mixtures |
10/10/2012 | EP2506838A1 Transdermal testosterone device and delivery |
10/10/2012 | EP2506837A2 Spider silk particles for controlled and sustained delivery of compounds |
10/10/2012 | EP2506831A2 Carboxyvinyl polymer-containing nanoparticle suspension |
10/10/2012 | EP2506830A1 Ophthalmic emulsion |
10/10/2012 | EP2263654B1 Compositions for improving the oral absorption of antimicrobial agents |
10/10/2012 | CN1956734B Multi-vitamin and mineral nutritional supplements |
10/10/2012 | CN1956733B Dietary supplement and method of processing same |
10/10/2012 | CN1662251B Adjuvant enhanced immunotherapy |
10/10/2012 | CN1522156B Novel engineered superantigen for human therapy |
10/10/2012 | CN102725002A Agents, uses and methods |
10/10/2012 | CN102725001A Antiproliferative compounds, conjugates thereof, methods therefor, and uses thereof |
10/10/2012 | CN102724966A Target-aiming drug delivery system for diagnosis and treatment of cancer containing liposome labeled with peptides which specifically targets interleukin-4 receptors, and manufacturing method thereof |
10/10/2012 | CN102724965A Carboxyvinyl polymer-containing nanoparticle suspensions |
10/10/2012 | CN102724961A Topical foam composition |
10/10/2012 | CN102724960A Topical foam composition |
10/10/2012 | CN102718991A High strength injectable hydrogel and preparation method thereof |
10/10/2012 | CN102718977A Heparin sodium-loaded polyurethane micro nanometer particle solution and preparation method and application thereof |
10/10/2012 | CN102718903A Transgenic non-viral vector of guanidinated polyvinyl alcohol, preparation method thereof and application thereof |
10/10/2012 | CN102718868A Fixed point mono-substituted pegylation of Exendin analogue and preparation method thereof |
10/10/2012 | CN102718856A Recombinant chromatin modified albumin 1A, as well as coding gene and application thereof |
10/10/2012 | CN102718254A Mesoporous titanium dioxide and preparation method thereof and application thereof |
10/10/2012 | CN102716500A Cationic macromolecular proteolipid gene medicine carrier, preparation method and application |
10/10/2012 | CN102716497A Alpha1,3 galactosyltransferase-transfected material, its preparation method and application |
10/10/2012 | CN102716496A Clathrate compound of scutellarin and alkaline cyclodextrin and preparation method thereof |
10/10/2012 | CN102716495A Multifunctional poly(malic acid) carried drug for targeting treatment of tumors |
10/10/2012 | CN102716494A Nucleic acid medicine loading system for targeted therapy and preparation method of nucleic acid medicine loading system |
10/10/2012 | CN102716493A Copolymer containing amorphous agomelatine, and preparation method, pharmaceutical composition and application thereof |
10/10/2012 | CN102716492A Baicalin hydroxypropyl-beta-cyclodextrin inclusion compound as well as preparation method and application thereof |
10/10/2012 | CN102716491A Clathrate compound of artemisinin series and alkaline cyclodextrin and method for preparing same |
10/10/2012 | CN102716490A Method for preparation of pharmaceutical composition having improved disintegradability |
10/10/2012 | CN102716489A Modified starch composition plant capsule and preparation method thereof |
10/10/2012 | CN102716488A Glycyrrhizic acid aureola dimer mediated targeted medication body as well as preparation method and purpose of glycyrrhizic acid aureola dimer mediated targeted medication body |
10/10/2012 | CN102716487A Permeation enhancer for improving transdermal absorption of Ginsenoside-Rd and application thereof |
10/10/2012 | CN102716478A Combined Newcastle disease and infectious bronchitis inactivated vaccine and method for preparing same |
10/10/2012 | CN102716477A Stability of protein in aqueous solution |
10/10/2012 | CN102716469A Dry powder inhalant of interferon alpha |
10/10/2012 | CN102716463A Glycyrrhizic acid organic salt phospholipid ligand and preparation thereof |
10/10/2012 | CN102716171A Compound common andrographis herb taste-masking particles and preparation method thereof |
10/10/2012 | CN102716161A Chinese medicinal ointment for treating scar hyperplasia |
10/10/2012 | CN102716158A In-water type mecamylamine and celery seed oil nanoemulsion antihypertensive medicine |
10/10/2012 | CN102716150A Zinc sulfate syrup oral liquid preparation |
10/10/2012 | CN102716138A Medicinal composition of diammonium glycyrrhizinate sodium chloride |
10/10/2012 | CN102716137A Preparation method and application of fluorescence nanometer diamond-doxycycline compound |
10/10/2012 | CN102716130A Transformable acupoint injection ligustrazine medicine and method for preparing same |
10/10/2012 | CN102716125A Vinpocetine composition and preparation method thereof |
10/10/2012 | CN102716105A Dry powder inhalant of interferon Alpha |
10/10/2012 | CN102716104A Medical organic silicon patch and preparation method thereof |
10/10/2012 | CN102716103A 2, 2', 6, 6'-tetraisopropyl-4, 4'-2-biphenol soft capsule and method for preparing same |
10/10/2012 | CN102716102A Mecobalamin tablet and preparation method thereof |
10/10/2012 | CN102716099A Levocetirizine hydrochloride chewable tablet and preparation method thereof |
10/10/2012 | CN102716098A Cefditoren pivoxil liposome solid preparation |
10/10/2012 | CN102716097A Method for controlling medicament release rate of orally disintegrating tablet |
10/10/2012 | CN102716096A Medicinal composition containing cefotiam hydrochloride |
10/10/2012 | CN102716095A Paclitaxel vesicle type phospholipid gel injection |
10/10/2012 | CN102716092A Formula of aureomycin hydrochloride premix granule and granulating process |
10/10/2012 | CN102716091A Method for preparing metoprolol tartrate particles |
10/10/2012 | CN102716090A Sustained-release metformin hydrochloride pellets and preparation method thereof |
10/10/2012 | CN102716089A Gemcitabine hydrochloride liposome injection |
10/10/2012 | CN102716088A Folate coupled chitosan ligustrazine nanoparticle preparation |
10/10/2012 | CN102716086A Carboxylated polyethylene glycol-polylactic acid segmented copolymer brucine nanoparticles and application thereof |
10/10/2012 | CN102716085A Topotecan hydrochloride liposome injection |
10/10/2012 | CN102716084A Fluoxetine hydrochloride liposome solid preparation |
10/10/2012 | CN102716083A Lafutidine liposome solid preparation and preparing method thereof |
10/10/2012 | CN102716082A Cefoxitin sodium liposome injection |
10/10/2012 | CN102716081A Docetaxel vesicle type phospholipid gel injection |
10/10/2012 | CN102716079A Pirenoxine-containing suspension-type aqueous preparation |
10/10/2012 | CN102716076A Ambroxol hydrochloride medicine combination for injection |
10/10/2012 | CN102716075A Ceftizoxime sodium-containing pharmaceutical composition |
10/10/2012 | CN102716074A Bimatoprost eye drops and preparation method thereof |
10/10/2012 | CN102716073A Medical carboxymethyl chitosan anti-adhesion agent and preparation method thereof |
10/10/2012 | CN102716072A Method for preparing ciprofloxacin lactate sodium chloride injection |
10/10/2012 | CN102716071A Fleroxacin mannitol injection and preparation method thereof |
10/10/2012 | CN102716070A Pinocembrin and cyclodextrin or cyclodextrin derivative clathrate compound |
10/10/2012 | CN102716069A Injection liquid containing ibuprofen and preparation process of injection liquid |